ロード中...
IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis
HIV-1 persistence in latent reservoirs during antiretroviral therapy (ART) is the main obstacle to virus eradication. To date, there is no marker that adequately identifies latently infected CD4(+) T cells in vivo. Using a well-established ex vivo model, we generated latently infected CD4(+) T cells...
保存先:
| 出版年: | JCI Insight |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5214598/ https://ncbi.nlm.nih.gov/pubmed/28097226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.85811 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|